The blood–ocular barriers (i.e. blood– retinal barrier that is equivalent to the blood–brain barrier (BBB) and blood–aqueous barrier) affect the ability of most systemic drugs to penetrate into the eye (posterior and anterior segments, respectively), thereby limiting the usefulness of this route